Companies / HMD

HERAMED LIMITED

ASX:HMDHealth Care Equipment & Services
1.16B shares on issueASX (delayed) · as of 28 July 2026$0.037price · delayed$42.9Mmarket cap · indicative
F
Dilution grade

Share count grew 83% in 24 months; runway 2–4 quarters; 5 cash raises in 24 months

Cash runway2.4 quarters of funding
Share-count growth (24m)83.0%
Raise cadence (24m)5 cash raises
Options & rights overhang19.0% of shares
In-the-money supply13.9% of shares
Pending proposed issuesnone

HERAMED LIMITED's ordinary share count grew 83.0% between June 2024 and June 2026, to 1.16B shares. The company raised capital five times in that period for total disclosed proceeds of A$10.8M, most recently a A$3.2M placement in January 2026. Options and rights on issue could convert into 220M new shares, equal to 19.0% of the current share count, of which 14% are in the money at the current share price; the nearest expiry is January 2027. At the March 2026 quarter the company reported A$2.0M in available cash, about 2.4 quarters of funding at its recent spending rate. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
19.0%
Max option dilution
13.9%
ITM option dilution
2
Raises · last 12 months
2.4 qtrs
Cash cover · 2–4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 1.16B per ASX (delayed) (28 July 2026).
0.87B0.97B1.08BDec 24Sept 25July 26Cash raise · 20 Jan 2026Cash raise · 4 Aug 2025Cash raise · 24 Dec 2024

Cash runway

2.4 qtrs
Two to four quarters of funding at the recent spend rate.
$2.0M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
24 July 20263H · cancellationHMD : ORDINARY FULLY PAID1.16BAppendix 3H
3 July 20263H · cancellationHMD : ORDINARY FULLY PAID1.16BAppendix 3H
24 June 20263G · unquotedHMD : ORDINARY FULLY PAID1.16BAppendix 3G
24 June 20263G · unquotedHMD : ORDINARY FULLY PAID1.16BAppendix 3G
19 June 20262A · quoted issueHMD : ORDINARY FULLY PAID1.16BAppendix 2A
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

5 cash raises in the last 24 months · 2 in the last 12 months

$3.2M
Placement
20 Jan 2026 COMPLETE
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

19.0%
Total overhang · of current shares
13.9%
In the money · at current price
220.2M
Potential new shares
Jan 2027
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
20 July 2026Timothy ChapmanSell5.3M4.5M—3Y notice
30 June 2026ANOUSHKA GUNGADINSell2.6M850k—3Y notice
9 June 2026David HintonOther430k3.0M—3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

24 July 2026Change of Director's Interest Notice - TC
24 July 2026Notification of cessation of securities - HMD
13 July 2026$PHeraMED successfully completes Phase 1 pilot with Lee Health
3 July 2026Notification of cessation of securities - HMD
3 July 2026Change of Director's Interest Notice - AG
24 June 2026Notification regarding unquoted securities - HMD
24 June 2026Notification regarding unquoted securities - HMD
19 June 2026Application for quotation of securities - HMD
15 June 2026Change of Director's Interest Notice TC AG DH SR
15 June 2026Notification regarding unquoted securities - HMD
21 May 2026Results of Meeting
11 May 2026Application for quotation of securities - HMD
30 Apr 2026$PQuarterly Activities & Cashflow Report
27 Apr 2026Change of Director's Interest Notice TC DH SR
27 Apr 2026Notification regarding unquoted securities - HMD
27 Apr 2026Notification regarding unquoted securities - HMD
21 Apr 2026Letter to Shareholders, Notice of AGM & Proxy Form
10 Apr 2026Notification regarding unquoted securities - HMD
10 Apr 2026Change of Director's Interest Notice - SR
1 Apr 2026Cleansing Notice

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.